Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: A prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)
Antoaneta Tomova, Rupert Bartsch, Thomas Brodowicz, Valentina Tzekova, Constanta Timcheva, Christoph Wiltschke, Dany Abi Gerges, Jan Pawlega, Stanislav Spanik, Moshe Inbar, Christoph C. Zielinski
Research output: Contribution to journal › Article › peer-review
16Scopus
citations
Fingerprint
Dive into the research topics of 'Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: A prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)'. Together they form a unique fingerprint.